Dror Bashan
Patrimonio netto: 6 M $ in data 31/07/2026
Patrimonio netto: 6 M $ in data 31/07/2026
Dror Bashan is currently President, Chief Executive Officer & Director at Protalix Biotherapeutics, Inc. since 2019.
Formerly, Mr. Bashan was Senior VP-Global Business Development at Teva Pharmaceutical Industries Ltd. Education includes undergraduate and MBA degrees from Tel-Aviv University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 30/04/2026 | 2.532.934 ( 3,14% ) | 6 M $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| PROTALIX BIOTHERAPEUTICS, INC. | Amministratore Delegato | 30/06/2019 |
| Società | Posizione | Fine |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 3 |
|---|---|
Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protalix Biotherapeutics, Inc.
Protalix Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets recombinant therapeutic proteins | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale